Key Financial Data Of Reporting Company

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7711657

Concept As at
2019-02-28
2018-03-01 to
2019-02-28
2018-03-01 to
2019-02-28
As at
2019-02-28
As at
2018-02-28
As at
2018-02-28
2017-03-01 to
2018-02-28
2017-03-01 to
2018-02-28
As at
2017-02-28
2016-03-01 to
2017-02-28
2016-03-01 to
2017-02-28
As at
2017-02-28
2015-03-01 to
2016-02-29
As at
2016-02-29
2015-03-01 to
2016-02-29
As at
2016-02-29
2014-03-01 to
2015-02-28
2014-03-01 to
2015-02-28
As at
2015-02-28
As at
2015-02-28
Key financial data of reporting company
Business results of reporting company
Net sales
143,408,000,000 JPY
109,269,000,000 JPY
112,505,000,000 JPY
148,466,000,000 JPY
145,962,000,000 JPY
112,777,000,000 JPY
161,895,000,000 JPY
119,459,000,000 JPY
120,125,000,000 JPY
156,791,000,000 JPY
Ordinary profit (loss)
24,647,000,000 JPY
19,916,000,000 JPY
21,369,000,000 JPY
28,245,000,000 JPY
28,179,000,000 JPY
22,706,000,000 JPY
28,008,000,000 JPY
26,295,000,000 JPY
27,836,000,000 JPY
28,489,000,000 JPY
Profit (loss)
15,944,000,000 JPY
14,621,000,000 JPY
16,741,000,000 JPY
16,928,000,000 JPY
18,413,000,000 JPY
Share capital
8,473,000,000 JPY
8,473,000,000 JPY
8,473,000,000 JPY
8,473,000,000 JPY
8,473,000,000 JPY
Total number of issued shares
95,164,895 xbrli:shares
95,164,895 xbrli:shares
95,164,895 xbrli:shares
95,164,895 xbrli:shares
95,164,895 xbrli:shares
Net assets
248,161,000,000 JPY
226,749,000,000 JPY
225,687,000,000 JPY
245,227,000,000 JPY
229,205,000,000 JPY
213,374,000,000 JPY
213,422,000,000 JPY
226,095,000,000 JPY
207,107,000,000 JPY
222,054,000,000 JPY
Total assets
297,512,000,000 JPY
260,274,000,000 JPY
264,930,000,000 JPY
299,913,000,000 JPY
278,820,000,000 JPY
248,353,000,000 JPY
251,134,000,000 JPY
284,954,000,000 JPY
247,245,000,000 JPY
285,440,000,000 JPY
Net assets per share
2,981.63
2,737.34
2,693.05
2,912.83
2,724.00
2,547.06
2,518.73
2,657.41
2,416.81
2,580.02
Dividend paid per share
82.50
82.00
81.50
81.00
80.00
Interim dividend paid per share
41.25
41.00
40.50
40.00
37.50
Basic earnings (loss) per share
230.08
190.96
174.70
228.52
241.27
197.98
208.81
198.71
214.88
219.28
Diluted earnings per share
229.86
190.77
174.57
228.35
241.15
197.88
208.76
198.65
Equity-to-asset ratio
0.828 xbrli:pure
0.870 xbrli:pure
0.851 xbrli:pure
0.813 xbrli:pure
0.817 xbrli:pure
0.858 xbrli:pure
0.849 xbrli:pure
0.790 xbrli:pure
0.838 xbrli:pure
0.774 xbrli:pure
Rate of return on equity
0.078 xbrli:pure
0.071 xbrli:pure
0.067 xbrli:pure
0.081 xbrli:pure
0.090 xbrli:pure
0.079 xbrli:pure
0.080 xbrli:pure
0.081 xbrli:pure
0.093 xbrli:pure
0.090 xbrli:pure
Price-earnings ratio
23.9 xbrli:pure
28.8 xbrli:pure
44.3 xbrli:pure
33.9 xbrli:pure
25.0 xbrli:pure
30.5 xbrli:pure
23.6 xbrli:pure
24.8 xbrli:pure
20.8 xbrli:pure
20.4 xbrli:pure
Payout ratio
0.432 xbrli:pure
0.469 xbrli:pure
0.412 xbrli:pure
0.408 xbrli:pure
0.372 xbrli:pure
Net cash provided by (used in) operating activities
15,772,000,000 JPY
30,453,000,000 JPY
19,910,000,000 JPY
30,923,000,000 JPY
23,232,000,000 JPY
Net cash provided by (used in) investing activities
-39,302,000,000 JPY
-1,378,000,000 JPY
1,070,000,000 JPY
-3,912,000,000 JPY
-8,945,000,000 JPY
Net cash provided by (used in) financing activities
-13,347,000,000 JPY
-7,153,000,000 JPY
-18,402,000,000 JPY
-11,616,000,000 JPY
-7,036,000,000 JPY
Cash and cash equivalents
88,782,000,000 JPY
126,569,000,000 JPY
105,610,000,000 JPY
103,940,000,000 JPY
88,614,000,000 JPY
Number of employees
2,792 xbrli:pure
1,596 xbrli:pure
1,595 xbrli:pure
2,823 xbrli:pure
2,751 xbrli:pure
1,581 xbrli:pure
1,580 xbrli:pure
2,900 xbrli:pure
1,548 xbrli:pure
2,942 xbrli:pure
Average number of temporary employees
636 xbrli:pure
298 xbrli:pure
318 xbrli:pure
899 xbrli:pure
630 xbrli:pure
329 xbrli:pure
310 xbrli:pure
583 xbrli:pure
311 xbrli:pure
626 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.